Prevalence of users of medication targeting obstructive lung disease, the reasons for prescriptions and the use of spirometry in Upernavik Health Center in the period from 2011-2016, a retrospective observational study as basis for future quality development

References

• Grønlands statistik intern ref. code BEXST4, optælling pr. 2016 January 1. og 2020.
   Google Scholar
• Koefoed MM, dePont Christensen R, Søndergaard J, et al. Lack of spirometry use in Danish patients initiating medi- cation targeting obstructive lung disease. Respir Med. 2012;106:1743–7.
   PubMed Web of Science ®Google Scholar
• Befolkningsundersoegelsen-i-groenland-2014.pdf LEVEVILKÅR, LIVSSTIL OG HELBRED, SIF’s Grønlandsskrifter nr. 28 (Statens Institut for Folkesundhed, Syddansk Universitet).
   Google Scholar
• From the Global Strategy for the Diagnosis, Management and Prevention of COPD. Global initiative for chronic obstructive. Lung Disease (GOLD); 2015 Available from: http://www.goldcopd.org/
   Google Scholar
• Vestbo J 1,2, Hurd SS 3, Agustı´ AG 4, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease GOLD executive summary 2013. Am J Respir Crit Care Med. 2013 Feb 15;187(4):347–365.
   PubMed Web of Science ®Google Scholar
• Olsen S, Jarbøl DE, Kofoed M, et al. Prevalence and management of patients using medication targeting obstructive lung disease: a cross-sectional study in primary healthcare in Greenland. Int J Circumpolar Health. 2013;72:20108.
   PubMed Web of Science ®Google Scholar
• Nielsen LO, et al. Spirometry in Greenland: a cross-sectional study on patients treated with medication targeting obstructive pulmonary disease. Int J Circumpolar Health. 2016;7(1):33258.
   Web of Science ®Google Scholar
• Reiss AE, Pedersen ML. Smoking among patients in the primary health care system in Nuuk, Greenland. Clin Nurs Stud. 2014 [cited 2016 Feb 24];2. Available from: http://www.sciedupress.com/journal/index.php/cns/article/view/4761
   Google Scholar
• Pedersen ML. Diabetes in Greenland 2008-2017. A new model on diabetes care in Greenland based on continued monitoring, analysis and adjustment of initiatives taken. Greenland Center of Health Research Institute of Nursing and Health Science; University of Greenland; 2018 (Thesis). p. 38–50.
   Google Scholar
• Pedersen ML, Jacobsen JL, Lynge AR, et al. Inuunerissarfiit.Livsstilsgrruppen, årsrapport 2013. og Benchmarking; 2013. Available from: Amisut.gl
   Google Scholar
• Pedersen ML, Rolskov A, Jacobsen JL. Frequent use of primary health care service in Greenland: an opportunity for undiagnosed disease case-finding. Int J Circumpolar Health. 2012;71. DOI:10.3402/ijch.v71i0.18431. Published online 2012 Jul 24. doi: 10.3402/ijch.v71i0.18431PMCID: PMC3417523.
   Web of Science ®Google Scholar
• Available from: https://naalakkersuisut.gl/en/About-government-of-greenland/About-Greenland/Facts-about-Greenlandn
   Google Scholar
• Choi J, Ki M, Kwon HJ, et al. Health Indicators related to disease, death, and reproduction. J Prev Med Public Health. 2019;52(1):14–20.
   Google Scholar
• Adeloye D, Chua S, Lee C, et al. Global and regional estimates of COPD prevalence: systematic review and meta-analysis. J Glob Health. 2015;5:020415.
   PubMed Web of Science ®Google Scholar
• Guirguis-Blake JM, Senger CA, Webber EM, et al. Screening for chronic obstructive pulmonary disease: a systematic evidence review for the U.S. preventive services task force [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2016 Apr. Report No.: 14-05205-EF-1. PMID: 27170970
   Google Scholar
• Blanco I, Diego I, Bueno P, et al. Geographic distribution of COPD prevalence in the world displayed by geographic information system maps. Eur Respir J. 2019 Jul;54(1):1900610.
   Web of Science ®Google Scholar
• Ospina MB 1, Voaklander D 1, Senthilselvan A 1, et al. Incidence and prevalence of chronic obstructive pulmonary disease among aboriginal peoples in Alberta, Canada.,2,5*. PLoS ONE. 2015;10(4):e0123204.
   Web of Science ®Google Scholar
• Halbert* RJ, Natoli* JL, Gano* A, et al. Global burden of COPD: systematic review and meta-analysis. Eur Respir J. 2006;28:523–532.
   Web of Science ®Google Scholar
• Alment praktiserende læge Jens Georg Hansen, chefstatistiker Lars Pedersen, forskningsoverlæge Kim Overvad, overlæge Øyvind Omland, overlæge Henrik Kirstein Jensen & professor Henrik Toft Sørensen. Prævalensen of kronisk obstruktiv lungesygdom – sekundærpublikation. Ugeskr Læger 171/41-42 5; 2009 oktober.
   Google Scholar
• Mapel DW, Dalal AA, Johnson P, et al. A clinical study of COPD severity assessment by primary care physicians and their patients compared with spirometry. Am J Med. 2015;128:629–637.
   PubMed Web of Science ®Google Scholar
• Gottlieb V, Lyngsø AM, Sæbye D, et al. The use of COPD maintenance therapy following spirometry in general practice. Eur Clin Respir J. 2016 June;3:30232.
   PubMed Web of Science ®Google Scholar
• Joish VN, Brady E, Stockdale W, et al. Evaluating diagnosis and treatment patterns of COPD in primary care. Treat Respir Med. 2006;5(4):283e93.
   Google Scholar
• Ernst P 1, Saad N 2, Suissa S. Inhaled corticosteroids in COPD: the clinical evidence, Review. Eur Respir J. 2015 Feb;45(2):525–537. Epub 2014 Dec 23.
   PubMed Web of Science ®Google Scholar
• Ferguson GT, Calverley PMA, Anderson JA, et al. Prevalence and progression of osteoporosis with COPD. Chest J. 2009;136:1456–1465.
   PubMed Web of Science ®Google Scholar
• Graat-Verbom L, Wouters EF, Smeenk FW, et al. Current status of research on osteoporosis in COPD: a systematic review. Eur Respir J. 2009;34:209–218.
   Web of Science ®Google Scholar
• Kallerup H, et al. Longitudinal observational study of quality development for identification, diagnosis, treatment and follow up on patients with COPD in the area of Upernavik Healthcare Center, Upernavik town and settlements in the period from 1. 1.2016-31.12.2019. (In præparation).
   Google Scholar